MinireviewOpioid receptor-coupled second messenger systems
References (141)
Cell
(1984)- et al.
Biochim Biophys Acta
(1990) - et al.
J. Biol. Chem.
(1983) - et al.
J. Biol. Chem.
(1984) - et al.
J. Biol. Chem.
(1984) - et al.
J. Biol. Chem.
(1985) - et al.
J. Biol. Chem.
(1986) - et al.
J. Biol. Chem.
(1985) - et al.
J. Biol. Chem.
(1988) - et al.
J. Biol. Chem.
(1983)
J. Biol. Chem.
J. Biol. Chem.
Life Sci.
Brain Res. Bull.
Life Sci.
Neuropharm.
J. Biol. Chem.
J. Biol. Chem.
J. Biol. Chem.
Neurosci. Lett.
Biochem. Biophys. Res. Commun.
Brain Res.
J. Biol. Chem.
Biochem. Biophys. Res. Commun.
Brain Res.
FEBS Lett.
Int. Rev. Cytol.
J. Biol. Chem.
Biochem. Pharmacol.
J. Biol. Chem.
FEBS Lett.
Life Sci.
Life Sci.
Prog. Neurobiol.
Nature
Cold Spring Harb. Quant. Biol.
Nature
Mol. Pharmacol.
Science
Biochemistry
Nature
Nature
Nature
Cited by (437)
Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics
2023, NeuropharmacologyCitation Excerpt :Presynaptic MOR signaling has been studied extensively in the vlPAG because activation of vlPAG output neurons occurs through inhibition of GABA release in the vlPAG, termed disinhibition (Lau and Vaughan, 2014). MORs inhibit both glutamate and GABA release from presynaptic terminals impinging on vlPAG neurons (Chieng and Christie, 1994b; Vaughan and Christie, 1997; Vaughan et al., 1997b). Presynaptic MORs also disinhibit RVM neurons via inhibition of GABA release (Pan et al., 1990).
Nanobiosensors for detection of opioids: A review of latest advancements
2022, European Journal of Pharmaceutics and BiopharmaceuticsCitation Excerpt :Opioids activate the pain pathways of serotonin and noradrenaline from the brain stem. The stimulation of NMDA receptors leads to tolerance development and neuropathic pain [36,37]. Both µ and δ opiates suppress the spinal nociceptive reflex, reducing the spine's neuronal activity via noxious stimuli.
Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: A systematic review
2020, Drug and Alcohol Dependence